Table 3.
CHA2DS2-VASc score | |||||
---|---|---|---|---|---|
0-1 | 2 | 3 | 4 | ≥5 | |
No AF, Number of participants | 4976 | 3282 | 1800 | 498 | 115 |
1 Year of follow-up | |||||
# of Ischemic stroke events | 4 | 13 | 5 | 6 | 4 |
Person-years | 4959 | 3266 | 1790 | 489 | 114 |
Incidence rate (95% CI) | 0.81 (0.27-1.92) | 3.98 (2.23-6.61) | 2.79 (1.06-6.12) | 12.3 (5.10-25.3) | 35.1 (11.7-83.4) |
5 Years of follow-up | |||||
# of Ischemic stroke events | 29 | 57 | 38 | 15 | 6 |
Person-years | 24407 | 15874 | 8660 | 2299 | 523 |
Incidence rate (95% Cl) | 1.19 (0.81-1.68) | 3.59 (2.75-4.62) | 4.39 (3.15-5.96) | 6.52 (3.81-10.5) | 11.5 (4.8-23.6) |
10 Years of follow-up | |||||
# of Ischemic stroke events | 62 | 101 | 81 | 28 | 8 |
Person-years | 47370 | 30351 | 16310 | 4151 | 897 |
Incidence rate (95% CI)‡ | 1.31 (1.01-1.67) | 3.33 (2.73-4.03) | 4.97 (3.97-6.14) | 6.75 (4.58-9.61) | 8.9(4.20-16.8) |
Abbreviations: AF, atrial fibrillation; CI, confidence interval. |
Excluding and censoring anticoagulant use at baseline and follow up
The data in this row was also reported in Table 2
The p-value for trend of the CHA2DS2-VASc score for ischemic stroke was <0.0001 for the 1, 5, and 10 year follow-up years